Junho Carolina Victoria Cruz, Trentin-Sonoda Mayra, Panico Karine, Dos Santos Raquel Silva Neres, Abrahão Mariana Vieira, Vernier Imara Caridad Stable, Fürstenau Cristina Ribas, Carneiro-Ramos Marcela Sorelli
Laboratory of Cardiovascular Immunology, Center of Natural and Human Sciences (CCNH), Federal University of ABC, Santo Andre, SP, Brazil.
Division of Nephrology, Department of Medicine, Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Heart Fail Rev. 2022 Nov;27(6):2137-2153. doi: 10.1007/s10741-022-10218-w. Epub 2022 Feb 8.
Almost 200 years ago, the first evidence described by Robert Bright (1836) showed the strong interaction between the kidneys and heart and, since then, the scientific community has dedicated itself to better understanding the mechanisms involved in the kidney-heart relationship, known in recent decades as cardiorenal syndrome (CRS). This syndrome includes a wide clinical variety that affects the kidneys and heart, in an acute or chronic manner. Moreover, it is well established in the literature that the immune system, the sympathetic nervous system, the renin-angiotensin-aldosterone, and the oxidative stress actively play a strong role in the cellular and molecular processes present in CRS. More recently, uremic molecules and epigenetic factors have been also shown to be key mediators in the development of syndrome. The present review intends to present the state of the art regarding CRS and to show the paths known, until now, in the long road between the kidneys and heart.
大约200年前,罗伯特·布莱特(1836年)描述的首个证据表明了肾脏与心脏之间存在着密切的相互作用。从那时起,科学界就致力于更好地理解参与肾心关系的机制,近几十年来这种关系被称为心肾综合征(CRS)。该综合征包括多种以急性或慢性方式影响肾脏和心脏的临床类型。此外,文献中已充分证实,免疫系统、交感神经系统、肾素-血管紧张素-醛固酮系统以及氧化应激在CRS的细胞和分子过程中发挥着重要作用。最近,尿毒症分子和表观遗传因素也被证明是该综合征发展过程中的关键介质。本综述旨在介绍CRS的最新研究现状,并展示迄今为止在肾脏与心脏之间漫长道路上已知的途径。